The Effects of Topical Calcium Glycerophosphate on Surgical Wound Healing and Residual Scarring (TOPCGP-2008)
A Randomized, Single Blind, Comparative, Controlled Study On The Effects Of Topical Calcium Glycerophosphate On Surgical Wound Healing And Residual Scarring In Bilateral Total Knee Arthroplasty Patients
Sponsor: AkPharma Inc.
A NA clinical study on Scarring and Wound Healing, this trial is completed. The trial is conducted by AkPharma Inc. and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2017 — Jan 2021 [monthly]
Completed NA
First recorded
Apr 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AkPharma Inc.
- Bacharach Institute for Rehabilitation, Pomona, NJ
- Cyberderm Inc.
- Rothman Institute Orthopaedics
- Texas Tech University Health Sciences Center
For direct contact, visit the study record on ClinicalTrials.gov .